Shaji K. Kumar, MD
Mayo Clinic in Rochester · Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shaji K. Kumar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:11 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06151717 · A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple MyelomaMayo Clinic · completed · Multiple Myeloma · principal investigator
- Ph1NCT06042725 · MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple MyelomaMayo Clinic · active not recruiting · Multiple Myeloma · principal investigator
- N/ANCT05918185 · Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple MyelomaMayo Clinic · completed · Plasma Cell Myeloma · principal investigator
- Ph2NCT05497804 · Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH TrialMayo Clinic · active not recruiting · ISS Stage III Plasma Cell Myeloma, Multiple Myeloma · principal investigator
- Ph2NCT00772915 · Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaMayo Clinic · completed · Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph2NCT00635024 · Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple MyelomaMayo Clinic · terminated · Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph2NCT00564889 · Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic AmyloidosisMayo Clinic · completed · Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph2NCT00478218 · Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaMayo Clinic · completed · Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph1/Ph2NCT00474929 · Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaMayo Clinic · completed · Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Biostatistics and Bioinformatics CoreP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Amylou Constance Dueck · fiscal years 2015 to 2026Named on NCT05497804
- Pathology Research Shared ResourceP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI THOMAS J FLOTTE · fiscal years 2015 to 2026
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.